Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07401680
What this trial is testing

Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesClostridioides Difficile Infection
University of Alberta 85
Not applicableStudy completedNCT00566306
What this trial is testing

Influence of a New Polycationic Disinfectant on Clostridium Difficile Incidence and Environmental Colonisation

Who this might be right for
Clostridium Difficile
University of Helsinki 200
Not applicableUnknownNCT05709184
What this trial is testing

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Rambam Health Care Campus 196
Large-scale testing (Phase 3)Study completedNCT02274285
What this trial is testing

DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 424
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Testing effectiveness (Phase 2)Study completedNCT00317174
What this trial is testing

Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.

Who this might be right for
Haemophilus Influenzae Type bTetanusWhole Cell Pertussis+2 more
GlaxoSmithKline 450
Post-approval studies (Phase 4)Study completedNCT01498640
What this trial is testing

Retreatment of Recurrent Dupuytren's Contractures

Who this might be right for
Dupuytren's Disease
Endo USA Inc., a Keenova Therapeutics Company 52
Testing effectiveness (Phase 2)Looking for participantsNCT06306014
What this trial is testing

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients

Who this might be right for
Clostridioides Difficile InfectionRecurrent Infection
Hospices Civils de Lyon 56
Post-approval studies (Phase 4)WithdrawnNCT00304863
What this trial is testing

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Who this might be right for
EnterocolitisPseudomembranous ColitisAntibiotic-associated Colitis
Michael E. DeBakey VA Medical Center
Early research (Phase 1)Not Yet RecruitingNCT05852587
What this trial is testing

Xylitol Use for Decolonization of C. Difficile in Patients With IBD

Who this might be right for
Inflammatory Bowel DiseasesClostridioides Difficile Infection
Brigham and Women's Hospital 99
Large-scale testing (Phase 3)Study completedNCT01598311
What this trial is testing

CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006)

Who this might be right for
Clostridium Difficile Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 608
Large-scale testing (Phase 3)Study completedNCT01261611
What this trial is testing

Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia

Who this might be right for
Cervical Dystonia
Ipsen 382
Early research (Phase 1)Study completedNCT06692179
What this trial is testing

An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection

Who this might be right for
Recurrent Clostridioides Difficile InfectionColonic Surgery
University of Minnesota 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Early research (Phase 1)Study completedNCT06607380
What this trial is testing

A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus Vaccine

Who this might be right for
Tetanus
Zhuhai Trinomab Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01106092
What this trial is testing

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

Who this might be right for
Haemophilus Influenzae Type bTetanusHepatitis B+3 more
GlaxoSmithKline 312
Not applicableEnded earlyNCT01441271
What this trial is testing

Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis

Who this might be right for
Clostridium Difficile Colitis
Massachusetts General Hospital 1
Post-approval studies (Phase 4)Study completedNCT03466502
What this trial is testing

Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics

Who this might be right for
Clostridium Difficile Infection
University of Nevada, Reno 104
Large-scale testing (Phase 3)Study completedNCT01441557
What this trial is testing

Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of Botulism

Who this might be right for
Botulism
Centre Hospitalier Universitaire, Amiens 3
Large-scale testing (Phase 3)Study completedNCT01340937
What this trial is testing

V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Who this might be right for
Bacterial InfectionsVirus Diseases
Merck Sharp & Dohme LLC 2,808
Next Page